Cited by 178Alzheimer's disease research and treatmentsProtease and Inhibitor MechanismsPeptidase Inhibition and Analysis

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

Open access

Malito, E., Hulse, R. E., Tang, W.-J.·2008·Cellular and Molecular Life Sciences

DOI 10.1007/s00018-008-8112-4PMC PMC2756532

Open this paper in CoChat — free account

Abstract

The accumulation of aggregates of amyloidogenic peptides is associated with numerous human diseases. One well studied example is the association between deposition of amyloid beta (Abeta) and Alzheimer's disease. Insulin degrading enzyme and neprilysin are involved in the clearance of Abeta, and presequence peptidase is suggested to play a role in the degradation of mitochondrial Abeta. Recent structural analyses reveal that these three peptidases contain a catalytic chamber (crypt) that selectively encapsulates and cleaves amyloidogenic peptides, hence the name cryptidase. The substrate selectivity of these cryptidases is determined by the size and charge distribution of their crypt as well as the conformational flexibility of substrates. The interaction of Abeta with the catalytic core of these cryptidases is controlled by conformational changes that make the catalytic chambers accessible for Abeta binding. These new structural and biochemical insights into cryptidases provide potential therapeutic strategies for the control of Abeta clearance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00018-008-8112-4

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397

Show all 89 references

Research works printed but not linked: 15

[1]Puente XS Sanchez LM Overall CM Lopez-Otin C 2003 Human and mouse proteases: a comparative genomic approach Nat Rev Genet 4 544 58 12838346
[3]Im H Manolopoulou M Malito E Shen Y Zhao J Neant-Fery M Sun CY Meredith SC Sisodia SS Leissring MA Tang WJ 2007 Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE J Biol Chem 282 25453 63 17613531
[5]Oefner C D'Arcy A Hennig M Winkler FK Dale GE 2000 Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon J Mol Biol 296 341 9 10669592
[9]Hartmann-Petersen R Gordon C 2004 Proteins interacting with the 26S proteasome Cell Mol Life Sci 61 1589 95 15224183 PMC11138787
[21]Tanzi RE Moir RD Wagner SL 2004 Clearance of Alzheimer's Abeta peptide: the many roads to perdition Neuron 43 605 8 15339642
[26]Rawlings ND Morton FR Barrett AJ 2006 MEROPS: the peptidase database Nucleic Acids Res 34 D270 2 16381862 PMC1347452
[31]Selkoe DJ 2001 Clearing the brain's amyloid cobwebs Neuron 32 177 80 11683988
[41]Taubes G 2003 Neuroscience. Insulin insults may spur Alzheimer's disease Science 301 40 1 12843374
[43]Maskos K Messerschmidt A Dode W Cygler M 2004 Handbook of metalloproteins John Wiley &Sons 3 190 198
[47]Mzhavia N Berman YL Qian Y Yan L Devi LA 1999 Cloning, expression, and characterization of human metalloprotease 1: a novel member of the pitrilysin family of metalloendoproteases DNA Cell Biol 18 369 80 10360838
[49]Lustbader JW Cirilli M Lin C Xu HW Takuma K Wang N Caspersen C Chen X Pollak S Chaney M Trinchese F Liu S Gunn-Moore F Lue LF Walker DG Kuppusamy P Zewier ZL Arancio O Stern D Yan SS Wu H 2004 ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 448 52 15087549
[53]Turner AJ Tanzawa K 1997 Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX Faseb J 11 355 64 9141502
[55]Eckman EA Reed DK Eckman CB 2001 Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme J Biol Chem 276 24540 8 11337485
[57]Iwata N Takaki Y Fukami S Tsubuki S Saido TC 2002 Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging J Neurosci Res 70 493 500 12391610
[94]Sticht H Bayer P Willbold D Dames S Hilbich C Beyreuther K Frank RW Rosch P 1995 Structure of amyloid A4-(1–40)-peptide of Alzheimer's disease Eur J Biochem 233 293 8 7588758

Sorted by citations

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308
The role of microglia in amyloid clearance from the AD brain
Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline
Fu, A. K. Y., Hung, K.-W., Yuen, M. Y. F., Zhou, X., Mak, D. S. Y., Chan, I. C. W., Cheung, T. H., Zhang, B., Fu, W.-Y., Liew, F. Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604032113 · Cited by 369
Natriuretic peptide metabolism, clearance and degradation
Potter, L. R. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08082.x · Cited by 359
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Baranello, R., Bharani, K., Padmaraju, V., Chopra, N., Lahiri, D., Greig, N., Pappolla, M., & Sambamurti, K. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218140953 · Cited by 331
Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer’s Disease
Ding, M., Shen, Y., Wang, P., Xie, Z., Xu, S., Zhu, Z., Wang, Y., Lyu, Y., Dewei, W., Xu, L., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2641-5 · Cited by 282
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W., Charron, M. J., Seeliger, M. A., Saghatelian, A., et al. (2014) · Nature · doi:10.1038/nature13297 · Cited by 258
Self-citation
Mitochondrial sirtuins
Huang, J.-Y., Hirschey, M. D., Shimazu, T., Ho, L., & Verdin, E. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.12.021 · Cited by 231
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
Nalivaeva, N. N., Beckett, C., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 169
Pathological role of hypoxia in Alzheimer's disease
Zhang, X., & Le, W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 190
Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
Kurochkin, I. V., Guarnera, E., & Berezovsky, I. N. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.008 · Cited by 185
Toward a comprehensive neurobiology of IGF‐I
Torres‐Alemán, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20778 · Cited by 177
Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model
Yang, H., Xie, Z., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z., Wang, P., Zhao, C., & Bi, J. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt227 · Cited by 167
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhang, Z., Liang, W. G., Bailey, L. J., Tan, Y. Z., Wei, H., Wang, A., Farcasanu, M., Woods, V. A., McCord, L. A., Lee, D. E., et al. (2018) · eLife · doi:10.7554/elife.33572 · Cited by 150
Self-citation
Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor
Costa, R., Ferreira-da-Silva, F., Saraiva, M., & Cardoso, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002899 · Cited by 128
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
Tang, W. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.11.003 · Cited by 126
Self-citation
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
Tzeng, T.-T., Chen, C., Lee, L., Wan-Ping, C., Chung-Kuang, L., Shen, C., Chi-Ying, H. F., Chien-Chih, C., & Shiao, Y. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0266-z · Cited by 127
The storm before the quiet: neuronal hyperactivity and aβ in the presymptomatic stages of Alzheimer’s disease
Stargardt, A., Swaab, D. F., & Bossers, K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.014 · Cited by 109
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Leissring, M. A., Malito, E., Hédouin, S., Reinstatler, L. S., Sahara, T., Abdul‐Hay, S. O., Choudhry, S., Maharvi, G. M., Fauq, A. H., Huzarska, M. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010504 · Cited by 108
Self-citation
Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme
Manolopoulou, M., Guo, Q., Malito, E., Schilling, A. B., & Tang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900068200 · Cited by 108
Self-citation
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP / PS 1 transgenic mice
Feng, J., Wang, J., Du, Y., Liu, Y., Zhang, W., Chen, J., Liu, Y., Zheng, M., Wang, K., & He, G. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12983 · Cited by 107
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Deprez-Poulain, R. F., Hennuyer, N., Bosc, D., Liang, W. G., Waeckel-Énée, E., Marechal, X., Charton, J., Totobenazara, J., Berte, G., Jahklal, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9250 · Cited by 97
Self-citation
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Inflammasome-mediated innate immunity in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900439 · Cited by 93
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Zhao, J., Li, L., & Leissring, M. A. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-4 · Cited by 90
Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme
Guo, Q., Manolopoulou, M., Bian, Y., Schilling, A. B., & Tang, W. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.072 · Cited by 92
Self-citation
Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications
Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150379 · Cited by 90
Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme
Malito, E., Ralat, L. A., Manolopoulou, M., Tsay, J. L., Wadlington, N. L., & Tang, W. (2008) · Biochemistry · doi:10.1021/bi801192h · Cited by 92
Self-citation
Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response
Ralat, L. A., Guo, Q., Ren, M., Funke, T., Dickey, D. M., Potter, L. R., & Tang, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173252 · Cited by 78
Self-citation
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
Cabrol, C., Huzarska, M. A., Dinolfo, C., Rodríguez, M. C., Reinstatler, L. S., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., Selkoe, D. J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005274 · Cited by 79
The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid β peptide 42/40 ratio in healthy elderly persons: a randomized controlled trial
Yokoyama, H., Okazaki, K., Imai, D., Yamashina, Y., Takeda, R., Naghavi, N., Ota, A., Hirasawa, Y., & Miyagawa, T. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0058-4 · Cited by 76
Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of β-Secretase in a Mouse Model of Alzheimer’s Disease
He, P., Cheng, X., Staufenbiel, M., Li, R., & Shen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055091 · Cited by 75
Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease
Webster, C. I., Burrell, M. R., Olsson, L., Fowler, S. A., Digby, S., Sandercock, A. M., Snijder, A., Tebbe, J., Haupts, U. M., Grudzinska, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104001 · Cited by 73
Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin‐Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer’s Disease
Grasso, G., Pietropaolo, A., Spoto, G., Pappalardo, G., Tundo, G. R., Ciaccio, C., Coletta, M., & Rizzarelli, E. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201002809 · Cited by 72
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
McCord, L. A., Liang, W. G., Dowdell, E., Kalas, V., Hoey, R. J., Koide, A., Koide, S., & Tang, W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304575110 · Cited by 79
Self-citation
Protease Regulation: The Yin and Yang of Neural Development and Disease
Bai, G., & Pfaff, S. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.012 · Cited by 70
Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome
Zhao, X., & Yang, J. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100067e · Cited by 68
Chapter 22 Structure, Function, and Regulation of Insulin‐Degrading Enzyme
Hulse, R. E., Ralat, L. A., & Wei‐Jen, T. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00622-5 · Cited by 69
Self-citation
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 67
Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease
Pardeshi, R., Bolshette, N. B., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 67
Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases
Sousa, L., Guarda, M., Meneses, M. J., Macedo, M. P., & Miranda, H. V. (2021) · The Journal of Pathology · doi:10.1002/path.5777 · Cited by 67
Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease
King, J. V. L., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W. (2014) · Structure · doi:10.1016/j.str.2014.05.003 · Cited by 62
Self-citation
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
Maianti, J. P., Tan, G. A., Vetere, A., Welsh, A. J., Wagner, B. K., Seeliger, M. A., & Liu, D. R. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0271-0 · Cited by 61
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo
Durham, T. B., Toth, J. L., Klimkowski, V. J., Cao, J. X. C., Siesky, A. M., Alexander-Chacko, J. T., Wu, G. Y., Dixon, J. T., McGee, J. E., Wang, Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638205 · Cited by 51
Comparison between the digestive behaviors of a new in vitro rat soft stomach model with that of the in vivo experimentation on living rats – Motility and morphological influences
Chen, L., Wu, X., & Chen, X. D. (2013) · Journal of Food Engineering · doi:10.1016/j.jfoodeng.2013.02.003 · Cited by 50
Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease
Gupta, S. N., Yadav, K., Mantri, S. S., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0985-0 · Cited by 48
SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model
Sim, A. Y., Choi, D. H., Kim, J. Y., Kim, E. R., Goh, A. R., Lee, Y., & Lee, J. E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115755 · Cited by 48
Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition
Thiankhaw, K., Chattipakorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130097 · Cited by 44
DNA-encoded chemical libraries of macrocycles
Connors, W. H., Hale, S. P., & Terrett, N. K. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.02.004 · Cited by 41
Ubiquitin Is a Novel Substrate for Human Insulin-Degrading Enzyme
Ralat, L. A., Kalas, V., Zheng, Z., Goldman, R. D., Sosnick, T. R., & Tang, W. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.026 · Cited by 43
Self-citation
Metallostasis and amyloid β-degrading enzymes
Grasso, G., Giuffrida, M. L., & Rizzarelli, E. (2012) · Metallomics · doi:10.1039/c2mt20105d · Cited by 41
Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation
Zraika, S., Aston‐Mourney, K., Marek, P., Hull, R. L., Green, P. S., Udayasankar, J., Subramanian, S. L., Raleigh, D. P., & Kahn, S. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082032 · Cited by 41
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer’s Disease and Type 2 Diabetes Mellitus
Kaminari, A., Tsilibary, E. C., & Tzinia, A. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180035 · Cited by 39
Crystal and Solution Structures of a Prokaryotic M16B Peptidase: an Open and Shut Case
Aleshin, A. E., Gramatikova, S. I., Hura, G. L., Bobkov, A. A., Strongin, A. Y., Stec, B., Tainer, J. A., Liddington, R., & Smith, J. W. (2009) · Structure · doi:10.1016/j.str.2009.09.009 · Cited by 38
Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation
Ralat, L. A., Ren, M., Schilling, A. B., & Tang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030627 · Cited by 39
Self-citation
Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues
Kochkina, E. G., Plesneva, S. A., Vasilev, D. S., Zhuravin, I. A., Turner, A. J., & Nalivaeva, N. N. (2015) · Biogerontology · doi:10.1007/s10522-015-9569-9 · Cited by 37
Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme
Çakır, B., Dağliyan, O., Dağyildiz, E., Barış, İ., Kavaklı, İ. H., Kızılel, S., & Türkay, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031787 · Cited by 37
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
Charton, J., Gauriot, M., Guo, Q., Hennuyer, N., Marechal, X., Dumont, J., Hamdane, M., Pottiez, V., Landry, V., Spérandio, O., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.009 · Cited by 36
Self-citation
Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
Wang, W., Gopal, S., Pocock, R., & Xiao, Z. (2019) · Molecules · doi:10.3390/molecules24244604 · Cited by 36
Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease
Gough, M., Parr-Sturgess, C. A., & Parkin, E. T. (2010) · Biochemistry Research International · doi:10.1155/2011/721463 · Cited by 37
How our bodies fight amyloidosis: Effects of physiological factors on pathogenic aggregation of amyloidogenic proteins
Huang, L., Liu, X., Cheng, B., & Huang, K. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.01.007 · Cited by 34
The Origins of Specificity in the Microcin-Processing Protease TldD/E
Ghilarov, D., Serebryakova, M. V., Stevenson, C. E. M., Hearnshaw, S. J., Volkov, D. S., Maxwell, A., Lawson, D. M., & Severinov, K. (2017) · Structure · doi:10.1016/j.str.2017.08.006 · Cited by 34
The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme
de Tullio, M. B., Morelli, L., & Castaño, E. M. (2008) · Prion · doi:10.4161/pri.2.2.6710 · Cited by 34
The clearance of misfolded proteins in neurodegenerative diseases by zinc metalloproteases: An inorganic perspective
Malgieri, G., & Grasso, G. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.10.008 · Cited by 33
Effects of the gastric juice injection pattern and contraction frequency on the digestibility of casein powder suspensions in an in vitro dynamic rat stomach made with a 3D printed model
Zhang, X., Liao, Z., Wu, P., Chen, L., & Chen, X. D. (2018) · Food Research International · doi:10.1016/j.foodres.2017.12.082 · Cited by 32
A novel pectin from Polygala tenuifolia blocks Aβ42 aggregation and production by enhancing insulin-degradation enzyme and neprilysin
Zeng, H., Li, P., Zhou, L., & Ding, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.212 · Cited by 32
Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice
Shi, X., Zhang, H., Zhou, Z., Ruan, Y., Pang, J., Zhang, L., Zhai, W., & Hu, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.099 · Cited by 30
Intracellular FRET-based Screen for Redesigning the Specificity of Secreted Proteases
Guerrero, J. L., O’Malley, M., & Daugherty, P. S. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01051 · Cited by 29
Anti-Amnesic Effect of Walnut via the Regulation of BBB Function and Neuro-Inflammation in Aβ1-42-Induced Mice
Kim, J. M., Lee, U., Kang, J. Y., Park, S. K., Shin, E. J., Kim, H., Kim, C. W., Kim, M.-J., & Heo, H. J. (2020) · Antioxidants · doi:10.3390/antiox9100976 · Cited by 30
JD-30, an active fraction extracted from Danggui–Shaoyao–San, decreases β-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice
Hu, Z.-Y., Liu, G., Cheng, X., Huang, Y. Y., Yang, S., Shan-yi, Q., Sun, L., Zhou, W., & Zhang, Y. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.09.009 · Cited by 30
Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia
Rajji, T. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1550074 · Cited by 30
Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme
Charton, J., Gauriot, M., Totobenazara, J., Hennuyer, N., Dumont, J., Bosc, D., Marechal, X., Bakali, J. E., Herlédan, A., Wen, X., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.005 · Cited by 29
Self-citation
Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients
Leal, N. S., Dentoni, G., Schreiner, B., Kämäräinen, O., Partanen, N., Herukka, S., Koivisto, A. M., Hiltunen, M., Rauramaa, T. H., Leinonen, V., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0605-2 · Cited by 29
Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer’s disease
Liu, M., Guo, H., Li, C., Wang, D., Wu, J., Wang, C., Xu, J., & Ren-an, Q. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0906-y · Cited by 28
Nitric Oxide Decreases the Enzymatic Activity of Insulin Degrading Enzyme in APP/PS1 Mice
Kummer, M. P., Hülsmann, C., Hermes, M., Axt, D., & Heneka, M. T. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9339-7 · Cited by 26
Structures of Human CCL18, CCL3, and CCL4 Reveal Molecular Determinants for Quaternary Structures and Sensitivity to Insulin-Degrading Enzyme
Liang, W. G., Ren, M., Zhao, F., & Tang, W. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.012 · Cited by 26
Self-citation
High resolution crystal structure of substrate-free human neprilysin
Moss, S., Subramanian, V., & Acharya, K. R. (2018) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.06.004 · Cited by 25
Insulin-Degrading Enzyme: Paradoxes and Possibilities
Leissring, M. A. (2021) · Cells · doi:10.3390/cells10092445 · Cited by 25
Characterization of plasma metal profiles in Alzheimer’s disease using multivariate statistical analysis
Guan, C., Dang, R., Cui, Y., Liu, L., Chen, X., Wang, X., Zhu, J., Li, D., Li, J., & Wang, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178271 · Cited by 26
Mechanisms of peptide and phosphoester hydrolysis catalyzed by two promiscuous metalloenzymes (insulin degrading enzyme and glycerophosphodiesterase) and their synthetic analogues
Hu, Q., Jayasinghe‐Arachchige, V. M., Sharma, G., Serafim, L. F., Paul, T. J., & Prabhakar, R. S. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1466 · Cited by 25
The solution of nitrogen inversion in amidases
Syrén, P. (2013) · FEBS Journal · doi:10.1111/febs.12241 · Cited by 23
Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review
Azam, M. S., Wahiduzzaman, M., Reyad‐ul‐Ferdous, M., Islam, M. N., & Roy, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03237-7 · Cited by 23
Crystal structure of peptide‐bound neprilysin reveals key binding interactions
Moss, S., Subramanian, V., & Acharya, K. R. (2019) · FEBS Letters · doi:10.1002/1873-3468.13602 · Cited by 22
Target Enzymes Considered for the Treatment of Alzheimer’s Disease and Parkinson’s Disease
Kim, N., & Lee, H. J. (2020) · BioMed Research International · doi:10.1155/2020/2010728 · Cited by 22
Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease
Liu, H., & Le, W. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-7 · Cited by 21
Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition
Liang, W. G., Wijaya, J., Wei, H., Noble, A. J., Mancl, J. M., Mo, S., Lee, D. E., King, J. V. L., Pan, M., Liu, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29322-4 · Cited by 21
Self-citation
Distinct chemical factors in hydrolytic reactions catalyzed by metalloenzymes and metal complexes
Serafim, L. F., Jayasinghe‐Arachchige, V. M., Wang, L., Rathee, P., Yang, J., Moorkkannur, S. N., & Prabhakar, R. S. (2023) · Chemical Communications · doi:10.1039/d3cc01380d · Cited by 20
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design
Tundo, G. R., Grasso, G., Persico, M., Tkachuk, O., Bellia, F., Bocedi, A., Marini, S., Parravano, M., Graziani, G., Fattorusso, C., et al. (2023) · Biomolecules · doi:10.3390/biom13101492 · Cited by 21
Structural changes in intermediate filament networks alter the activity of insulin‐degrading enzyme
Chou, Y.-H., Kuo, W.-L., Rosner, M. R., Tang, W., & Goldman, R. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-137455 · Cited by 20
Self-citation
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
Shropshire, T. D., Reifert, J. R., Rajagopalan, S., Baker, D. A., Feinstein, S. C., & Daugherty, P. S. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0230 · Cited by 20
Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme
Yang, D., Qin, W., Shi, X., Zhu, B., Xie, M., Zhao, H., Teng, B., Wu, Y., Zhao, R., Yin, F., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00418 · Cited by 19
Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
Nakagawa, H., & Saito, Y. (2022) · Biology · doi:10.3390/biology11071017 · Cited by 19
Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer’s Disease and Aβ Plaque Management
Cerasuolo, M., Auriemma, M. C., Meo, I. D., Lenti, C., Papa, M., Paolisso, G., & Rizzo, M. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146693 · Cited by 18
Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
Azargoonjahromi, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae066 · Cited by 17
The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update
Yasmin, S., Ashique, S., Taj, T., Garg, A. K., Das, J., Shorog, E., Bhui, U., Pal, R., Selim, S., Panigrahy, U. P., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149400 · Cited by 18
The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
Karczewska‐Kupczewska, M., Lelental, N., Adamska, A., Nikołajuk, A., Kowalska, I., Górska, M., Zimmermann, R., Kornhuber, J., Strączkowski, M., & Lewczuk, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.013 · Cited by 18

Authors: Malito, E., Hulse, R. E., & Tang, W.-J.
Affiliations: University of Chicago (US)
Corresponding author: Tang, W.-J.
ORCID: Malito, E.
Hulse, R. E.
Tang, W.-J.
Venue: Cellular and Molecular Life Sciences
Publisher: Springer Science and Business Media LLC
Published: 2008-05-13
Volume: 65
Issue: 16
Pages: 2574-2585
ISSN: 1420-682X (ISSN-L)
1420-9071
DOI: 10.1007/s00018-008-8112-4
PMC: PMC2756532
OpenAlex: W2007899228
Cited by: 176
References: 89
Citations by year: 2026: 4 · 2025: 13 · 2024: 5 · 2023: 14 · 2022: 8 · 2021: 9 · 2020: 5 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 9 · 2015: 17 · 2014: 12 · 2013: 12 · 2012: 6
FWCI: 8.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Cellular and Molecular Life Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (R01 GM81539, T32GM007839, R01GM081539, T32GM07839)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Keywords: amyloid-beta, insulin-degrading enzyme, neprilysin, amyloid-beta clearance, Alzheimer's disease, substrate specificity, conformational flexibility, peptide aggregation
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Humans, Insulysin, Molecular Sequence Data, Protein Processing, Post-Translational, Substrate Specificity, Neprilysin, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks